Every SEC Form 3/4/5 on record for this filer (CIK 1190644) — 5 issuers, 32 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| RLAY | Relay Therapeutics, Inc. | Director | 2020-07-15 → 2026-06-10 | 8 | $500,000 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Director | 2025-02-07 → 2025-12-18 | 3 | — |
| SRPT | Sarepta Therapeutics, Inc. | Chief Executive Officer · Director | 2017-06-28 → 2025-12-09 | 14 | $14M |
| ENDP | Endo International plc | Director · lapsed | 2016-05-09 → 2017-06-12 | 4 | −$120,001 |
| NMUS | Nemus Bioscience, Inc. | Vice Chairman · Director · lapsed | 2015-08-24 → 2015-10-22 | 2 | — |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| SRPT | 2023-11-03 | Buy | 3,884 | $80.33 | $312,002 | 390,107 |
| SRPT | 2023-11-03 | Buy | 10,081 | $78.57 | $792,064 | 375,163 |
| SRPT | 2023-11-03 | Buy | 11,060 | $79.70 | $881,482 | 386,223 |
3 of 5 issuers are covered and open a security page; the rest are on file here only.
